Drug Eluting Stent (DES) in Primary Angioplasty
Condition(s):Acute Myocardial InfarctionLast Updated:September 25, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Acute Myocardial InfarctionLast Updated:September 25, 2008Completed
Condition(s):HypertensionLast Updated:February 22, 2024Active, not recruiting
Condition(s):Myocardial Ischemia; Acute Coronary SyndromeLast Updated:February 15, 2022Completed
Condition(s):Coronary Heart DiseaseLast Updated:April 1, 2021Unknown status
Condition(s):Adverse Reaction to Antiplatelet Agent; Acute Coronary SyndromeLast Updated:July 29, 2016Terminated
Condition(s):Chronic Kidney DiseasesLast Updated:July 29, 2021Recruiting
Condition(s):Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Heart FailureLast Updated:May 14, 2015Terminated
Condition(s):Coronary Artery DiseaseLast Updated:February 1, 2024Not yet recruiting
Condition(s):Cardiovascular Diseases; Heart Diseases; Myocardial Infarction; Heart Failure, Congestive; Heart FailureLast Updated:April 21, 2014Completed
Condition(s):Pancreatic Cancer Metastatic; Pancreatic Adenocarcinoma MetastaticLast Updated:October 11, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.